Applications from the field of Pharma & Biopharma focused on LC/SQ - page 9

Open paper Extending the Analytics of Biopharmaceutical QA/QC Labs with the ACQUITY™ QDa™ II Mass Detector

Extending the Analytics of Biopharmaceutical QA/QC Labs with the ACQUITY™ QDa™ II Mass Detector

LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Enhancing Efficiency: Fast and Reliable Nitrite Content Analysis in Pharmaceutical Excipients With the ACQUITY™ QDa™ II Mass Detector

Enhancing Efficiency: Fast and Reliable Nitrite Content Analysis in Pharmaceutical Excipients With the ACQUITY™ QDa™ II Mass Detector

LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Supporting Pharmaceutical Synthetic Process R&D Using LC-MS

Supporting Pharmaceutical Synthetic Process R&D Using LC-MS

LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Oligonucleotide Mass Confirmation and Impurity Identification

Oligonucleotide Mass Confirmation and Impurity Identification

LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Open paper Streamlining Impurity Analysis in Atorvastatin with the ACQUITY™ QDa™ II Mass Detector for Enhanced Detection and Quantification

Streamlining Impurity Analysis in Atorvastatin with the ACQUITY™ QDa™ II Mass Detector for Enhanced Detection and Quantification

LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Method Development of Proteolysis Targeting Chimera (PROTAC) Compound ARV-825 Forced Degradation Sample Using the Systematic Screening Protocol

Method Development of Proteolysis Targeting Chimera (PROTAC) Compound ARV-825 Forced Degradation Sample Using the Systematic Screening Protocol

LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Development of Separation Methods for GLP-1 Synthetic Peptides Utilizing a Systematic Protocol and MaxPeak™ High Performance Surface Technology

Development of Separation Methods for GLP-1 Synthetic Peptides Utilizing a Systematic Protocol and MaxPeak™ High Performance Surface Technology

LC/MS, LC/SQ, HPLC
Instrumentation
LC/MS, LC/SQ, HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Method Development for the Chromatographic Separation of Synthetic Cyclic Peptides and Impurities Utilizing a Systematic Protocol and MaxPeak High Performance Surface Technology

Method Development for the Chromatographic Separation of Synthetic Cyclic Peptides and Impurities Utilizing a Systematic Protocol and MaxPeak High Performance Surface Technology

HPLC, LC/MS, LC/SQ
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Process Monitoring of Monoclonal Antibody Subunits for Fast, Critical Quality Attribute Monitoring Using the ACQUITY QDa Detector

Process Monitoring of Monoclonal Antibody Subunits for Fast, Critical Quality Attribute Monitoring Using the ACQUITY QDa Detector

LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Oligonucleotide Characterization for Quality Control on the Shimadzu LCMS-2050

Oligonucleotide Characterization for Quality Control on the Shimadzu LCMS-2050

LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Shimadzu
Industries
Pharma & Biopharma